KRAS mutations in codon @ ( multivariate HR , @ ; @ % confidence interval , CI , @-@ @ ; P < @ ) or codon @ ( multivariate HR , @ ; @ % CI , @-@ @ ; P = @ ) were significantly associated with shorter DFS compared with patients with wild-type KRAS/BRAF tumors , independent of covariates .